Effect of mutations in LDLR and PCSK9 genes on phenotypic variability in Tunisian familial hypercholesterolemia patients

被引:23
|
作者
Slimani, Afef [1 ]
Jelassi, Awatef [1 ]
Jguirim, Imen [1 ]
Najah, Mohamed [1 ]
Rebhi, Lamia [2 ]
Omezzine, Asma [2 ]
Maatouk, Faouzi [3 ]
Ben Hamda, Khaldoun [3 ]
Kacem, Maha [4 ]
Rabes, Jean-Pierre [5 ]
Abifadel, Marianne [6 ]
Boileau, Catherine [5 ,7 ]
Rouis, Mustapha [8 ]
Slimane, Mohamed Naceur [1 ]
Varret, Mathilde [7 ]
机构
[1] Fac Med, Unit Res Genet & Biol Factors Atherosclerosis, Monastir 5000, Tunisia
[2] Sahloul Univ Hosp, Dept Biochem, URMSP 28 04, Sousse, Tunisia
[3] Fattouma Bourguiba Hosp, Dept Cardiovasc Dis, Monastir 5000, Tunisia
[4] Farhat Hachad Hosp, Dept Endocrinol, Sousse, Tunisia
[5] Univ Versailles St Quentin En Yvelines, Hop A Pare, AP HP, Versailles, France
[6] Univ St Joseph, Fac Pharm, Beirut, Lebanon
[7] Univ Paris Denis Diderot, CHU Xavier Bichat, INSERM, U698, Paris, France
[8] Univ Paris 06, UMR Physiol & Physiopathol 7079, Paris, France
关键词
Familial hypercholesterolemia; LDLR gene; PCSK9; gene; Phenotypic variability; APOLIPOPROTEIN-E; CHOLESTEROL LEVELS; POLYMORPHISMS; SPECTRUM; VARIANT;
D O I
10.1016/j.atherosclerosis.2012.02.018
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Autosomal dominant hypercholesterolemia (ADH) is commonly caused by mutations in the low-density lipoprotein (LDL) receptor gene (LDLR), in the apolipoprotein B-100 gene (APOB), or in the proprotein convertase subtilisin kexine 9 gene (PCSK9). ADH subjects carrying a mutation in LDLR present highly variable plasma LDL-cholesterol (LDL-C). This variability might be due to environmental factors or the effect of some modifying genes such as PCSK9 and APOE. Aims: We investigated the molecular basis of thirteen Tunisian ADH families and attempted to determine the impact of PCSK9 and APOE gene variations on LDL-cholesterol levels and on the variable phenotypic expression of the disease. Methods and results: Fifty six subjects were screened for mutations in the LDLR gene through direct sequencing. The causative mutation was found to segregate with the disease in each family and a new frameshift mutation, p.Met767CysfsX21, was identified in one family. The distribution of total-and LDL-cholesterol levels, adjusted for age and gender, among homozygous and heterozygous ADH patients varied widely. Within seven families, nine subjects presented low LDL-cholesterol levels despite carrying a mutation in the LDLR gene. To identify the molecular actors underlying this phenotypic variability, the PCSK9 gene was screened using direct sequencing and/or enzymatic restriction analysis, and the apo E genotypes were determined. A new missense variation (p.Pro174Ser) in the PCSK9 gene was identified and characterized as a new putative loss-of-function mutation. Conclusion: Genetic variations in PCSK9 and APOE genes could explain only part of the variability observed in the phenotypic expression in Tunisian ADH patients carrying mutations in the LDLR gene. Other genetic variants and environmental factors very probably act to fully explain this phenotypic variability. (C) 2012 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:158 / 166
页数:9
相关论文
共 50 条
  • [11] The Molecular Basis of Familial Hypercholesterolemia in Lebanon: Spectrum of LDLR Mutations and Role of PCSK9 as a Modifier Gene
    Abifadel, Marianne
    Rabes, Jean-Pierre
    Jambart, Selim
    Halaby, Georges
    Gannage-Yared, Marie-Helene
    Sarkis, Antoine
    Beaino, Ghada
    Varret, Mathilde
    Salem, Nabiha
    Corbani, Sandra
    Aydenian, Hermine
    Junien, Claudine
    Munnich, Arnold
    Boileau, Catherine
    HUMAN MUTATION, 2009, 30 (07) : E682 - E691
  • [12] Mutational Spectrum of LDLR and PCSK9 Genes Identified in Iranian Patients With Premature Coronary Artery Disease and Familial Hypercholesterolemia
    Moradi, Arman
    Maleki, Majid
    Ghaemmaghami, Zahra
    Khajali, Zahra
    Noohi, Feridoun
    Moghadam, Maryam Hosseini
    Kalyinia, Samira
    Mowla, Seyed Javad
    Seidah, Nabil G.
    Malakootian, Mahshid
    FRONTIERS IN GENETICS, 2021, 12
  • [13] SCREENING FOR PCSK9 MUTATIONS IN SPANISH PATIENTS WITH AUTOSOMAL DOMINANT HYPERCHOLESTEROLEMIA UNRELATED TO LDLR OR APOB
    Garcia-Otin, L.
    Strunk, M.
    Pueyo, M.
    Solanas, M.
    Fiddyment, S.
    Aceves, M.
    Tejedor, D.
    Pocovi, M.
    Civeira, F.
    ATHEROSCLEROSIS SUPPLEMENTS, 2009, 10 (02)
  • [14] PCSK9 IN FAMILIAL HYPERCHOLESTEROLEMIA (FH)
    Lambert, G.
    Rye, K. -A.
    Burnett, J.
    Barter, P.
    Marais, D.
    ATHEROSCLEROSIS SUPPLEMENTS, 2011, 12 (01) : 31 - 31
  • [15] PCSK9 Inhibitors for Familial Hypercholesterolemia
    Lenahan, Christy M.
    Harringtoon, Deedra
    JNP-JOURNAL FOR NURSE PRACTITIONERS, 2016, 12 (08): : 577 - 578
  • [16] Role of PCSK9 Inhibitors in Patients with Familial Hypercholesterolemia
    Tomlinson, Brian
    Patil, Nivritti Gajanan
    Fok, Manson
    Lam, Christopher Wai Kei
    ENDOCRINOLOGY AND METABOLISM, 2021, 36 (02) : 279 - 295
  • [17] Genetic Polymorphisms in LDLR, APOB, PCSK9 and Other Lipid Related Genes Associated with Familial Hypercholesterolemia in Malaysia
    Lye, Say-Hean
    Chahil, Jagdish Kaur
    Bagali, Pramod
    Alex, Livy
    Vadivelu, Jamunarani
    Ahmad, Wan Azman Wan
    Chan, Siew-Pheng
    Thong, Meow-Keong
    Zain, Shamsul Mohd
    Mohamed, Rosmawati
    PLOS ONE, 2013, 8 (04):
  • [18] LIPOPROTEIN(A) IN FAMILIAL HYPERCHOLESTEROLEMIA WITH PCSK9 GAIN-OF-FUNCTION MUTATIONS
    Tada, Hayato
    Kawashiri, Masa-Aki
    Nohara, Atsushi
    Inazu, Akihiro
    Mabuchi, Hiroshi
    Yamagishi, Masakazu
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2016, 67 (13) : 1896 - 1896
  • [19] NEW GAIN OF FUNCTIONS MUTATIONS IN PCSK9 AND THEIR IMPACT IN FAMILIAL HYPERCHOLESTEROLEMIA
    AbiFadel, M.
    Rabes, J. -P.
    Guerin, M.
    Carreau, V.
    Carrie, A.
    Varret, M.
    Samson-Bouma, M. -E.
    Tosolini, L.
    Erlich, D.
    Couvert, P.
    Bonnefont-Rousselot, D.
    Bruckert, E.
    Prat, A.
    Seidah, N.
    Boileau, C.
    ATHEROSCLEROSIS SUPPLEMENTS, 2011, 12 (01) : 10 - 10
  • [20] Whole exome sequencing of familial hypercholesterolaemia patients negative for LDLR/APOB/PCSK9 mutations
    Futema, Marta
    Plagnol, Vincent
    Li, KaWah
    Whittall, Ros A.
    Neil, H. Andrew W.
    Seed, Mary
    Bertolini, Stefano
    Calandra, Sebastiano
    Descamps, Olivier S.
    Graham, Colin A.
    Hegele, Robert A.
    Karpe, Fredrik
    Durst, Ronen
    Leitersdorf, Eran
    Lench, Nicholas
    Nair, Devaki R.
    Soran, Handrean
    Van Bockxmeer, Frank M.
    Humphries, Steve E.
    JOURNAL OF MEDICAL GENETICS, 2014, 51 (08) : 537 - 544